.Merck trumps revenues desires, rears purchases expectation on sturdy demand for leading drugs like Keytruda CNBCMerck & Co. (MRK United States) Defeats Profit Estimates as Keytruda Purchases Rise BloombergMerck Inventory: Pharma Giant Posts Powerful Outcomes, Yet Expectation Tumbles Short Investor's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats revenue as well as sales requirements among Keytruda advantage, yet supplies combined full-year overview MarketWatch.